AbCellera Biologics Inc.
US ˙ NasdaqGS ˙ CA00288U1066

SecurityABCL / AbCellera Biologics Inc.
InstitutionAllworth Financial LP
Latest Disclosed Ownership15,401 shares
Latest Disclosed Value $ 53,750
Allworth Financial LP reports 36.61% increase in ownership of ABCL / AbCellera Biologics Inc.

On May 14, 2026 - Allworth Financial LP filed a 13F-HR form disclosing ownership of 15,401 shares of AbCellera Biologics Inc. (US:ABCL) valued at $53,749 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 11,274 shares of AbCellera Biologics Inc.. This represents a change in shares of 36.61% during the quarter. The current value of the position is $88,094 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 15,401 4,127 36.61 54 39.47 0.0002
2026-02-05 2025-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 11,274 10,096 857.05 39 660.00 0.0002
2025-12-02 2025-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 1,178 207 21.32 6 66.67 0.0000
2025-08-07 2025-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 971 69 7.65 3 50.00 0.0000
2025-04-30 2025-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 902 -380 -29.64 2 -50.00 0.0000
2025-01-30 2024-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,282 931 265.24 5 0.0000
2024-10-23 2024-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 351 351 1 0.0000
2024-01-24 2023-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 0 -335 -100.00 0 -100.00
2023-10-31 2023-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 335 290 644.44 2 0.0000
2023-07-18 2023-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 45 45 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.